Skip to main content

Danaher

Company Profile
danaher
Enterprise Value: £129bn
Region: North America
Theme:
Health
Website: danaher.com

Danaher is a diversified business that designs, manufactures and sells laboratory equipment, consumables and services to clinical and medical laboratories including microscopes, analytical software and imaging and molecular devices. These tools are used in the development of new drugs and for diagnosing critically ill patients.

Impact Score: 32%

Danaher provides test and measurement equipment for drug R&D, diagnosis, environment testing, food and water testing and academic research. The company’s products have a wide range of positive impacts. However, these may be incremental for example, through speeding up research and development or increasing efficiency and accuracy.

Fundamental Quality: 66%

Danaher has a strong market position as one of two major life science platforms. It has a focused management team and a clear, proven approach to operational improvements (known as the ‘Danaher Business System’). The company has focused its portfolio in recent years on the healthcare sector and has ambitious executive officer performance goals and an improving approach to environmental, social and governance issues.

Link to UN SDGs SDG 3
Danaher’s products provide the foundations for research and development of new and improved healthcare therapies supporting the achievement of SDG 3.
Learn more
Impact calculator metric
(per £1m invested)
Health:
<100 COVID tests provided
View our impact calculator
Recent stewardship topics
  • Sustainability strategy
Related
Danaher engagement case study shareholde...
Read now

Sign up to impact fund updates

Sign up below to receive email updates on our impact investment funds.
{{ errors[0] }}
{{ errors[0] }}
{{ errors[0] }}
{{ errors[0] }}
{{ errors[0] }}
{{ errors[0] }}
Authorised and regulated by the Financial Conduct Authority Copyright 2024© WHEB. All rights reserved Made by Thursday
How to invest